Return to homepagePandemic Pact

Advancing influenza vaccines for broad and durable protection

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA58839

Grant search

Key facts

  • Disease

    Unspecified

  • Start & end year

    2020
    2024

  • Known Financial Commitments (USD)

    $419,910.87

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Principal Investigator

    N/A

  • Research Location

    Australia

  • Lead Research Institution

    University of Melbourne

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Current influenza vaccines elicit poor protection against viruses undergoing rapid change. This proposal will define the potential for protective, cross-reactive antibody responses in humans and use this information to identify conserved sites of vulnerability on the hemagglutinin of influenza viruses. This will inform the development and assessment of novel influenza vaccine concepts in animal models of human influenza infection.